▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Phathom Pharmaceuticals (NASDAQ: PHAT)

$10.50

(-1.3%)

-$0.14

Price as of June 17, 2025, 4:00 p.m. ET

Phathom Pharmaceuticals Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
PHAT	-10.26%	-75.58%	-24.57%	-57%
S&P	+9.31%	+92.04%	+13.94%	+98%

Phathom Pharmaceuticals Company Info

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

News & Analysis

Featured Article

Why Shares of Phathom Pharmaceutical Jumped This Week

Investors are reading between the lines to see if the company is fixing its problems regarding its lead therapy.

Jim Halley | Jan 28, 2023

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services